3rd Annual Cell & Gene Therapy Congress
November 6 - 7, 2017 - London UKOxford Global
g.alonso@oxfordglobal.co.uk
Phone:+44 (0) 1865 248 455
Oxford Global Conferences presents its 3rd Annual Cell & Gene Therapy Congress, with our co-located 6th Annual Cell Culture & Bioprocessing Congress and 4th Annual Stem Cell Congress and, 6 - 7 of November 2017, London, UK. View Agenda: http://bit.ly/2b80uCZ 2 interactive streams: - Cell & Gene Therapy: Development & Clinical Trials - Cell Therapy Bioprocessing and Manufacturing Presentations will include cell & gene therapy development, updates in regulatory pathways, commercialisation, bioprocessing and manufacturing. 2017 Speakers Include: - David Sourdive, Co-founder, Executive Vice President Cellectis - Sven Kili, Vice President and Head of Gene Therapy Development GlaxoSmithKline - Gwendolyn Binder-Scholl, Chief Technology Officer Adaptimmune - Ajan Reginald, Executive Director & Co-founder Cell Therapy Ltd - Sylvain Arnould, Process Development & Production Director Celyad